Aspira Women’s Health (AWH)
搜索文档
Aspira Women’s Health (AWH) - 2019 Q4 - Annual Report
2020-04-08 04:09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-34810 Vermillion, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0595156 (State or Other Jurisd ...
Aspira Women’s Health (AWH) - 2019 Q4 - Earnings Call Transcript
2020-03-27 08:11
VRML (VRML) Q4 2019 Results Conference Call March 26, 2020 4:30 PM ET Company Participants Valerie Palmieri - President and CEO Bob Beechey - CFO Chris Goulart - SVP, Commercial Operations Conference Call Participants Jeb Terry - Aberdeen Investment Management Jack Fraser - Seamark Capital Operator Good afternoon, ladies and gentlemen, and welcome to the Vermillion’s Fourth Quarter 2020 (sic) [2019] Conference Call. My name is Doug, and I will be your coordinator for the call today. At this time, all partic ...
Aspira Women’s Health (AWH) - 2019 Q3 - Quarterly Report
2019-11-13 05:57
UNITED STATES SECURITIES AND EXCHANGE COMMISSION | --- | --- | |--------------|------------------------------------------| | | WASHINGTON, D.C. 20549 \nFORM 10-Q | | (Mark One) | | ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-34810 VERMILLION® Ver ...
Aspira Women’s Health (AWH) - 2019 Q2 - Quarterly Report
2019-08-09 05:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION | --- | --- | --- | |--------------|---------------------------|--------------| | | WASHINGTON, D.C. \nFORM | 20549 \n10-Q | | (Mark One) | | | ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-34810 VERMILLI ...
Aspira Women’s Health (AWH) - 2019 Q1 - Quarterly Report
2019-05-15 04:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION | --- | --- | --- | |--------------|----------------------------------------|-------| | | WASHINGTON, DC 20549 \nFORM 10-Q | | | (Mark One) | | | ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission file number: 001-34810 VERMI ...
Aspira Women’s Health (AWH) - 2018 Q4 - Earnings Call Transcript
2019-03-29 11:28
Vermillion, Inc. (VRML) Q4 2018 Earnings Conference Call March 28, 2019 4:30 PM ET Company Participants Valerie Palmieri - CEO, President & Director Robert Beechey - CFO Conference Call Participants Michael Brcic - National Securities Corporation Operator Good afternoon, ladies and gentlemen, and welcome to Vermillion's Fourth Quarter 2018 Conference Call. My name is Jeremy, and I will be your coordinator for the call today. [Operator Instructions]. As a reminder, this conference is being recorded today. L ...
Aspira Women’s Health (AWH) - 2018 Q4 - Annual Report
2019-03-29 05:29
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-34810 Vermillion, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0595156 (State or Other Jurisd ...